Azithromycin and COVID‐19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration
Author:
Affiliation:
1. Professor of Dermatology and Pathology Rutgers University New Jersey Medical School Newark New Jersy USA
2. Professor of Pediatrics and Founding Dean Emeritus California University of Science of Medicine San Bernardino California USA
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13785
Reference17 articles.
1. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
2. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
3. Hydroxychloroquine for covid‐19: the end of the line?;Mahase E;BMJ,2020
4. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine
5. Recommendations for the measurement of the QT interval during the use of drugs for COVID‐19 infection treatment. Updatable in accordance with the availability of new evidence;Asensio E;J Interv Card Electrophysiol,2020
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adverse drug reactions associated with COVID-19 management;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-14
2. Post-COVID-19 Neuropsychiatric Manifestations: A Suggested Therapeuptic Approach to “Long COVID” with Azithromycin;Epidemiology and Infection;2023-12-15
3. Use of a rapid triage assessment tool to discriminate the need for hospitalisation in patients with severe COVID-19 infection presenting to an outpatient clinic: a single-centre, prospective cohort study;BMJ Open;2023-11
4. Trends and patterns of antibiotics use in Serbia from 2006 to 2021: Pre-COVID-19 period versus COVID-19 pandemic;American Journal of Infection Control;2023-09
5. Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC;Current Pharmaceutical Analysis;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3